These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 12464442)

  • 21. Risk of prostate cancer among cancer survivors in the Netherlands.
    Kok DE; van de Schans SA; Liu L; Kampman E; Coebergh JW; Kiemeney LA; Soerjomataram I; Aben KK
    Cancer Epidemiol; 2013 Apr; 37(2):140-5. PubMed ID: 23265853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double primary cancers of the prostate and bladder: a literature review.
    Kinoshita Y; Singh A; Rovito PM; Wang CY; Haas GP
    Clin Prostate Cancer; 2004 Sep; 3(2):83-6. PubMed ID: 15479490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Second cancers in radically treated Norwegian prostate cancer patients.
    Aksnessæther BY; Lund JÅ; Myklebust TÅ; Klepp OH; Skovlund E; Roth Hoff S; Solberg A
    Acta Oncol; 2019 Jun; 58(6):838-844. PubMed ID: 30905229
    [No Abstract]   [Full Text] [Related]  

  • 24. Associations between ocular melanoma and other primary cancers: an international population-based study.
    Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P
    Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study.
    Pawlish KS; Schottenfeld D; Severson R; Montie JE
    Prostate; 1997 Oct; 33(2):75-86. PubMed ID: 9316648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is there an increased risk of second primaries following prostate irradiation?
    Movsas B; Hanlon AL; Pinover W; Hanks GE
    Int J Radiat Oncol Biol Phys; 1998 May; 41(2):251-5. PubMed ID: 9607337
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Does solar exposure, as indicated by the non-melanoma skin cancers, protect from solid cancers: vitamin D as a possible explanation.
    Tuohimaa P; Pukkala E; Scélo G; Olsen JH; Brewster DH; Hemminki K; Tracey E; Weiderpass E; Kliewer EV; Pompe-Kirn V; McBride ML; Martos C; Chia KS; Tonita JM; Jonasson JG; Boffetta P; Brennan P
    Eur J Cancer; 2007 Jul; 43(11):1701-12. PubMed ID: 17540555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of second cancer within 5 years of diagnosis of a breast, prostate or colorectal cancer: a population-based study.
    Cluze C; Delafosse P; Seigneurin A; Colonna M
    Eur J Cancer Prev; 2009 Sep; 18(5):343-8. PubMed ID: 19436213
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiation-induced secondary malignancy in prostate cancer: a systematic review and meta-analysis.
    Jin T; Song T; Deng S; Wang K
    Urol Int; 2014; 93(3):279-88. PubMed ID: 25139441
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk of second benign brain tumors among cancer survivors in the surveillance, epidemiology, and end results program.
    Kutsenko A; Berrington de Gonzalez A; Curtis RE; Rajaraman P
    Cancer Causes Control; 2014 Jun; 25(6):659-68. PubMed ID: 24682745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of second primary malignancies associated with radiotherapy in prostate cancer patients: competing risk analysis.
    Wu Y; Li Y; Han C; Chong Y; Kang K; Liu Z; Zhang F
    Future Oncol; 2022 Feb; 18(4):445-455. PubMed ID: 35018785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Higher than expected association of clinical prostate and bladder cancers.
    Singh A; Kinoshita Y; Rovito PM; Landas S; Silberstein J; Nsouli I; Wang CY; Haas GP
    J Urol; 2005 May; 173(5):1526-9. PubMed ID: 15821472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The risk of second malignancies after
    Fernandez Ots A; Browne L; Chin YS; Malouf D; Wong K; Bucci J
    Brachytherapy; 2016; 15(6):752-759. PubMed ID: 27475483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of second cancers in patients with colorectal carcinoids.
    Tichansky DS; Cagir B; Borrazzo E; Topham A; Palazzo J; Weaver EJ; Lange A; Fry RD
    Dis Colon Rectum; 2002 Jan; 45(1):91-7. PubMed ID: 11786770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second nonbreast malignancies after conservative surgery and radiation therapy for early-stage breast cancer.
    Galper S; Gelman R; Recht A; Silver B; Kohli A; Wong JS; Van Buren T; Baldini EH; Harris JR
    Int J Radiat Oncol Biol Phys; 2002 Feb; 52(2):406-14. PubMed ID: 11872286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of invasive cancers following squamous cell skin cancer.
    Levi F; Randimbison L; La Vecchia C; Erler G; Te VC
    Am J Epidemiol; 1997 Nov; 146(9):734-9. PubMed ID: 9366621
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.
    Michalski JM; Purdy JA; Winter K; Roach M; Vijayakumar S; Sandler HM; Markoe AM; Ritter MA; Russell KJ; Sailer S; Harms WB; Perez CA; Wilder RB; Hanks GE; Cox JD
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):391-402. PubMed ID: 10661346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidence of second tumors after treatment with or without radiation for rectal cancer.
    Rombouts AJM; Hugen N; Elferink MAG; Feuth T; Poortmans PMP; Nagtegaal ID; de Wilt JHW
    Ann Oncol; 2017 Mar; 28(3):535-540. PubMed ID: 27993790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.